Clinical Trial Update: Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of MEDI6570 in patients with a history of myocardial infarction and coronary heart disease has completed and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Myocardial Infarction

Drugs mentioned

• MEDI6570

Snippet

Sponsor: AstraZeneca | Conditions: Coronary Heart Disease (CHD) | Phase 2 | Status: COMPLETED | Results posted: 2025-02-21